Transdermal CBD No Better Than Placebo for Drug-Resistant Focal Epilepsy - HealthDay News
7/18/2022 12:00:00 AM2 years 9 months ago
by Physician’s Briefing Staff
by Physician’s Briefing Staff
At week 12, no difference in seizure frequency seen between cannabidiol and placebo as adjunctive therapy in adults
MONDAY, July 18, 2022 (HealthDay News) -- For adults with drug-resistant focal epilepsy, no difference in efficacy was observed at 12 weeks for adjunctive therapy with transdermal cannabidiol versus … [+1722 chars]
full article...